Experimental and Theoretical Studies on the Corrosion Inhibition of Brass in Hydrochloric Acid by N-(4-((4-Benzhydryl Piperazin-1-yl) Methyl Carbamoyl) Phenyl) Furan-2-Carboxamide

被引:18
|
作者
Zulfareen, N. [1 ]
Venugopal, T. [2 ]
Kannan, K. [2 ]
机构
[1] Mahendra Engn Coll, Dept Chem, Namakkal 637503, India
[2] Govt Coll Engn, Dept Chem, Salem 636011, India
关键词
D O I
10.1155/2018/9372804
中图分类号
O646 [电化学、电解、磁化学];
学科分类号
081704 ;
摘要
The corrosion inhibition effect of N-(4-((4-Benzhydryl piperazin-1-yl) methyl Carbamoyl) Phenyl) Furan-2-Carboxamide (BFC) on brass in M-1 HCl has been investigated using weight loss method, potentiodynamic polarization, electrochemical impedance spectroscopy (EIS), and cyclic voltammetry (CV). The result reveals that BFC acts as a mixed type corrosion inhibitor with more pronounced effect on anodic domain and the inhibition efficiency of BFC increases with increase in temperature ranges from 30 degrees C to 60 degrees C. AC impedance implies that R-ct value of BFC increases with increase in concentration. CV indicates that the addition of inhibitor controls the oxidation of the copper on the brass metal. The structural confirmation of BFC was carried out by the spectral studies like FT-IR, (HNMR)-H-1, C-13 NMR, and the molecular weight was confirmed by LC-MS. Surface characterization of brass with BFC was analysed using scanning electron microscope (SEM). Quantum chemical parameter was used to calculate the electronic properties of BFC in order to confirm the correlation between the inhibitor effect and molecular structure of BFC. BFC has more negative charge on nitrogen and oxygen atom, which facilitates the adsorption of BFC on the surface of brass.
引用
收藏
页数:18
相关论文
共 50 条
  • [41] Neuropharmacological Activity of the New Piperazine Derivative 2-(4-((1-Phenyl-1H-Pyrazol-4-yl)Methyl)Piperazin-1-yl)Ethyl Acetate is Modulated by Serotonergic and GABAergic Pathways
    Almeida, Lorena de Souza
    Cavalcante Santana, Ianca Gontijo
    da Silva Moreira, Lorrane Kelle
    Turones, Larissa Cordova
    Sanz, German
    Vaz, Boniek G.
    de Carvalho, Flavio S.
    Liao, Luciano M.
    Menegatti, Ricardo
    Costa, Elson Alves
    de Brito, Adriane Ferreira
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2022, 21 (06) : 520 - 532
  • [42] (S)-3-(4-(2-(5-Methyl-2-phenyloxazol-4-yl)ethoxy)phenyl)-2-(piperazin-1-yl)propanoic acid compounds: Synthesis and biological evaluation of dual PPARα/γ agonists
    Zhou, Xinbo
    Chen, Wei
    Xu, Cheng
    Fan, Shiyong
    Xie, Yunde
    Zhong, Wu
    Wang, Lili
    Li, Song
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (08) : 2605 - 2608
  • [43] Novel choline analog 2-(4-((1-phenyl-1H-pyrazol-4-yl)methyl)piperazin-1-yl)ethan-1-ol produces sympathoinhibition, hypotension, and antihypertensive effects
    Ricardo Menegatti
    Flávio S. Carvalho
    Luciano M. Lião
    Bianca Villavicencio
    Hugo Verli
    Aline A. Mourão
    Carlos H. Xavier
    Carlos H. Castro
    Gustavo R. Pedrino
    Octavio L. Franco
    Iransé Oliveira-Silva
    Nicole M. Ashpole
    Osmar Nascimento Silva
    Elson A. Costa
    James O. Fajemiroye
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2019, 392 : 1071 - 1083
  • [44] Novel choline analog 2-(4-((1-phenyl-1H-pyrazol-4-yl)methyl)piperazin-1-yl)ethan-1-ol produces sympathoinhibition, hypotension, and antihypertensive effects
    Menegatti, Ricardo
    Carvalho, Flavio S.
    Liao, Luciano M.
    Villavicencio, Bianca
    Verli, Hugo
    Mourao, Aline A.
    Xavier, Carlos H.
    Castro, Carlos H.
    Pedrino, Gustavo R.
    Franco, Octavio L.
    Oliveira-Silva, Iranse
    Ashpole, Nicole M.
    Silva, Osmar Nascimento
    Costa, Elson A.
    Fajemiroye, James O.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2019, 392 (09) : 1071 - 1083
  • [45] SYNTHESIS AND RADIOLABELING OF N-[4-[4-(2-[11C]METHOXYPHENYL)PIPERAZIN-1-YL]BUTYL] BENZO[b]THIOPHENE-2-CARBOXAMIDE, A POTENTIAL RADIOTRACER FOR D3 RECEPTOR IMAGING WITH PET
    Kuhnast, B.
    Demphel, S.
    Besret, L.
    Coulon, C.
    Ottaviani, M.
    Guillermier, M.
    Valette, H.
    Bottlaender, M.
    Dolle, F.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2005, 48 : S166 - S166
  • [46] N-(ω-(4-(2-methoxyphenyl)piperazin-1-yl)alkyl)carboxamides as dopamine D2 and D3 receptor ligands
    Hackling, A
    Ghosh, R
    Perachon, S
    Mann, A
    Höltje, HD
    Wermuth, CG
    Schwartz, JC
    Sippl, W
    Sokoloff, P
    Stark, H
    JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (18) : 3883 - 3899
  • [47] Synthesis and radiolabeling of N-[4-[4-(2-[11C]methoxyphenyl)piperazin-1-yl]butyl]benzo[b]thiophene-2-carboxamide -: a potential radiotracer for D3 receptor imaging with PET
    Kuhnast, Bertrand
    Valette, Heric
    Besret, Laurent
    Demphel, Stephane
    Coulon, Christine
    Ottaviani, Michele
    Guillermier, Martine
    Bottlaender, Michel
    Dolle, Fredreic
    NUCLEAR MEDICINE AND BIOLOGY, 2006, 33 (06) : 785 - 795
  • [48] N-(4-(4-(2-halogenophenyl)piperazin-1-yl)butyl) substituted cinnamoyl amide derivatives as dopamine D2 and D3 receptor ligands
    Saur, Oliver
    Hackling, Anneke E.
    Perachon, Sylvie
    Schwartz, Jean-Charles
    Sokoloff, Pierre
    Stark, Holger
    ARCHIV DER PHARMAZIE, 2007, 340 (04) : 178 - 184
  • [49] Synthesis, computational studies and preliminary pharmacological evaluation of 2 [4-(aryl substituted) piperazin-1-yl] N, N-diphenylacetamides as potential antipsychotics
    Kumar, Sushil
    Wahi, A. K.
    Singh, Ranjit
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2011, 46 (09) : 4753 - 4759
  • [50] Design, synthesis and anticancer activity of N-(1-(4-(dibenzo[bf][1,4] thiazepin-11-yl)piperazin-1-yl)-1-oxo-3-phenylpropan-2-yl derivatives
    Gudisela, Mura Reddy
    Srinivasu, N.
    Mulakayala, Chaitanya
    Bommu, Praveen
    Rao, M. V. Basaveswara
    Mulakayala, Naveen
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (17) : 4140 - 4145